文献速递炎症性肠病

肠道菌群与炎症性肠病患者健康相关生活质量受损的关联强于疾病活动度

Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease.
PubMed 文献 · Am J Gastroenterol · 2025-09-29

该研究基于澳大利亚IBD微生物组研究队列,纳入751名参与者(305名健康对照、232名克罗恩病、214名溃疡性结肠炎),采集粪便和口腔样本进行16S rRNA测序,并收集SF-36和IBDQ-32问卷。研究发现IBD患者健康相关生活质量低于健康对照,即使缓解率高,IBDQ-32评分受损仍常见(CD 42%,UC 41%),且菌群与生活质量的关联数量和强度超过其与临床及生化活动度的关联。

要点

  • IBD患者HRQoL低于健康对照,即使缓解率高,IBDQ-32受损仍常见。
  • IBDQ-32受损患者α多样性较低(Chao1 155.2 vs 172.4,P=0.015)。
  • 菌群与HRQoL的关联强于与临床及生化活动度的关联。

核心结论

  • 肠道菌群改变与IBD患者及健康对照的HRQoL结局相关。
  • 菌群与HRQoL的关联数量和强度超过其与临床及生化活动度的关联。

研究设计与样本

  • 基于澳大利亚IBD微生物组研究的基线横断面分析,纳入751名参与者(305名健康对照、232名克罗恩病、214名溃疡性结肠炎)。
  • 采集粪便和口腔样本进行16S rRNA测序,并收集SF-36和IBDQ-32问卷。
  • 使用R分析HRQoL变量与α多样性、β多样性及微生物分类群丰度的关联。

主要发现

  • IBD患者SF-36生理Component Summary为51.6 vs 健康对照55.7(P<0.0001),心理Component Summary为45.1 vs 52.2(P<0.001)。
  • 尽管缓解率高,IBDQ-32评分<170的HRQoL受损在CD中占42%、UC中占41%。
  • IBDQ-32受损患者α多样性较低(Chao1 155.2 vs 172.4,P=0.015),β多样性存在差异(R2=0.003,P=0.019)。

临床怎么用

  • 在IBD管理中除疾病活动度外,应关注HRQoL受损,即使患者处于缓解期。
  • 肠道菌群特征可能作为HRQoL受损的辅助评估维度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inflammatory bowel disease (IBD) affects health-related quality of life (HRQoL). Gut dysbiosis in IBD is common and may contribute to this observation. The aims of this study were to measure HRQoL and its association with clinical and microbial features in patients with IBD and healthy controls (HCs). METHODS: Fecal and oral samples, demographics, 36-item Short-Form Health Survey (SF-36), and 32-item Inflammatory Bowel Disease Questionnaire (IBDQ-32) surveys were collected at baseline from patients with Crohn's disease (CD), ulcerative colitis (UC) and HCs enrolled in The Australian IBD Microbiome Study. Samples underwent 16S rRNA sequencing. Associations between HRQoL variables and alpha diversity, beta diversity, and microbial taxa abundance were measured using R. RESULTS: A total of 751 participants (305 HCs, 232 CD, 214 UC) were included. HRQoL was lower in IBD participants compared with HCs using the SF-36 (physical component summary 51.6 vs 55.7, P < 0.0001 and mental component summary score 45.1 vs 52.2, P < 0.001). Despite high rates of remission, impaired IBD-HRQoL (IBDQ-32 score <170) was common in patients with CD (42%) and UC (41%). Patients with impaired IBDQ-32 scores demonstrated lower alpha diversity (Chao1 155.2 vs 172.4, P = 0.015) and distinct beta diversity ( R2 = 0.003, P = 0.019) compared with those with preserved IBD-HRQoL. Sixty-two genera were associated with at least one HRQoL measure in both patients with UC and patients with CD. The number and strength of associations between genera and HRQoL measures outweighed microbial associations with clinical and biochemical activity. DISCUSSION: Alterations in gut microbiota are associated with HRQoL outcomes in patients with IBD and HCs.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Little RD, Jayawardana TC, Zhang F, et al. Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease. Am J Gastroenterol. 2025. PMID: 41020656. doi:10.14309/ajg.0000000000003773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。